根治性膀胱切除术的替代选择:合适筛选患者中的保膀胱策略
根治性膀胱切除术(RC)是肌层浸润性膀胱癌(MIBC)的传统标准治疗,但并发症率常超过60%、90天死亡率较高且影响生活质量。本文综述保膀胱替代策略,其中三联治疗(TMT)已成为指南接受的RC替代方案,适用于合适筛选的MIBC患者;其他策略数据有限。保膀胱后需终身监测,约11-16%的当代TMT队列需 salvage RC。
要点
- TMT是指南接受的RC替代方案,适用于合适筛选的MIBC患者。
- TMT后约11-16%的当代队列需 salvage RC,监测至关重要。
- TMT的QoL结局优于RC,尤其保留排尿与性功能。
核心结论
- 保膀胱策略是合适筛选MIBC患者的合适RC替代方案,需多学科协作和终身监测。
研究设计与样本
- 本文为综述,检索范围未在摘要中报告。
主要发现
- RC并发症率常超过60%,90天死亡率较高,并显著影响生活质量。
- TMT包括最大程度TURBT后同步化疗和放疗(chemoRT),使用放射增敏剂。
- TMT后约11-16%的当代队列需 salvage RC。
- TMT的QoL结局一致优于RC,尤其保留排尿与性功能。
- TMT严重治疗相关毒性不常见,Grade ≥3不良事件发生率<10%。
关键数值与推荐
- TMT是指南接受的RC替代方案,适用于合适筛选的MIBC患者。
- TURBT单药或TURBT后系统治疗和监测用于达到完全临床缓解者,数据有限。
临床怎么用
- 对合适筛选的MIBC患者,可考虑TMT作为RC替代,需多学科协作和终身监测。
- 保膀胱后需适当监测,以便必要时及时行 salvage RC。
局限性
- TURBT单药或TURBT后系统治疗和监测的数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Radical cystectomy (RC) has historically been the standard treatment for muscle-invasive bladder cancer (MIBC); nonetheless, it is associated with a high morbidity and mortality, with complication rates often exceeding 60%, a relatively high 90-day mortality rate, as well as a significant impact on quality of life (QoL). This substantial burden has generated increasing interest in effective bladder-sparing alternatives. Among these approaches to bladder preservation, trimodal therapy (TMT), comprising maximal transurethral resection of bladder tumour (TURBT) followed by concurrent chemotherapy and radiotherapy (chemoRT) using radiosensitising agents, has become a guideline accepted alternative to RC in appropriately selected patients with MIBC. Additional bladder-sparing strategies, such as TURBT monotherapy or TURBT followed by systemic therapy and surveillance in those patients achieving a complete clinical response, may be alternatives in select settings, although data are limited. Appropriate surveillance after a bladder-sparing approach is paramount to offer timely salvage RC when needed, occurring in approximately 11-16% of contemporary TMT cohorts. QoL outcomes consistently favour TMT over RC, particularly in preserving urinary and sexual function. Severe treatment-related toxicity with TMT is uncommon, with Grade ≥3 adverse events occurring in <10% of cases. In conclusion, bladder-sparing approaches offer a suitable alternative to RC in appropriately selected patients with MIBC, incorporating multidisciplinary care and a commitment to lifelong surveillance.
引用
- Nolazco JI, Melnick KR, Lee RJ, et al. Alternatives to radical cystectomy: a bladder-sparing approach in appropriately selected patients. BJU Int. 2026. PMID: 41992552. doi:10.1111/bju.70211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。